Verition Fund Administration LLC lowered its place in shares of Elanco Animal Well being Integrated (NYSE:ELAN – Get Ranking) by 32.1% within the first quarter, in keeping with the corporate in its most up-to-date disclosure with the Securities & Change Fee. The fund owned 19,419 shares of the corporate’s inventory after promoting 9,192 shares through the quarter. Verition Fund Administration LLC’s holdings in Elanco Animal Well being had been price $507,000 on the finish of the newest reporting interval.
Numerous different institutional buyers and hedge funds have additionally added to or diminished their stakes within the inventory. Vanguard Group Inc. elevated its holdings in Elanco Animal Well being by 1.6% within the first quarter. Vanguard Group Inc. now owns 41,452,530 shares of the corporate’s inventory valued at $1,081,496,000 after buying a further 650,715 shares over the last quarter. Primecap Administration Co. CA elevated its holdings in Elanco Animal Well being by 2.1% within the first quarter. Primecap Administration Co. CA now owns 30,784,292 shares of the corporate’s inventory valued at $803,162,000 after buying a further 625,326 shares over the last quarter. Black Rock Inc. elevated its holdings in Elanco Animal Well being by 6.6% within the first quarter. Black Rock Inc. now owns 26,217,917 shares of the corporate’s inventory valued at $684,027,000 after buying a further 1,631,045 shares over the last quarter. Dodge & Cox elevated its holdings in Elanco Animal Well being by 510.5% within the fourth quarter. Dodge & Cox now owns 22,218,300 shares of the corporate’s inventory valued at $630,555,000 after buying a further 18,579,176 shares over the last quarter. Lastly, State Avenue Corp elevated its holdings in Elanco Animal Well being by 5.0% within the fourth quarter. State Avenue Corp now owns 12,576,000 shares of the corporate’s inventory valued at $356,907,000 after buying a further 595,779 shares over the last quarter. Institutional buyers personal 98.15% of the corporate’s inventory.
Insider Transactions at Elanco Animal Well being
In associated information, insider Rajeev A. Modi bought 6,700 shares of Elanco Animal Well being inventory in a transaction that occurred on Friday, September ninth. The inventory was bought at a median value of $14.90 per share, with a complete worth of $99,830.00. Following the completion of the transaction, the insider now owns 41,157 shares of the corporate’s inventory, valued at roughly $613,239.30. The acquisition was disclosed in a submitting with the SEC, which might be accessed via this hyperlink. In associated information, insider Rajeev A. Modi bought 6,700 shares of Elanco Animal Well being inventory in a transaction that occurred on Friday, September ninth. The inventory was bought at a median value of $14.90 per share, with a complete worth of $99,830.00. Following the completion of the transaction, the insider now owns 41,157 shares of the corporate’s inventory, valued at roughly $613,239.30. The acquisition was disclosed in a submitting with the SEC, which might be accessed via this hyperlink. Additionally, Director R David Hoover bought 20,000 shares of Elanco Animal Well being inventory in a transaction that occurred on Friday, September ninth. The shares had been purchased at a median value of $15.18 per share, with a complete worth of $303,600.00. Following the completion of the transaction, the director now instantly owns 145,000 shares of the corporate’s inventory, valued at roughly $2,201,100. The disclosure for this buy might be discovered right here. Insiders purchased 56,700 shares of firm inventory valued at $839,630 over the past three months. Firm insiders personal 6.40% of the corporate’s inventory.
Elanco Animal Well being Inventory Down 1.3%
ELAN inventory opened at $13.22 on Friday. The corporate has a debt-to-equity ratio of 0.84, a present ratio of two.47 and a fast ratio of 1.47. The inventory has a market capitalization of $6.27 billion, a P/E ratio of -37.77, a P/E/G ratio of 1.38 and a beta of 0.87. The enterprise has a 50-day shifting common of $17.36 and a 200-day shifting common of $21.60. Elanco Animal Well being Integrated has a fifty-two week low of $13.03 and a fifty-two week excessive of $35.00.
Elanco Animal Well being (NYSE:ELAN – Get Ranking) final posted its quarterly earnings knowledge on Monday, August eighth. The corporate reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.26 by $0.10. The corporate had income of $1.18 billion through the quarter, in comparison with analysts’ expectations of $1.18 billion. Elanco Animal Well being had a optimistic return on fairness of seven.40% and a detrimental internet margin of three.77%. Elanco Animal Well being’s income for the quarter was down 8.0% in comparison with the identical quarter final 12 months. Throughout the identical interval within the prior 12 months, the agency earned $0.28 earnings per share. On common, sell-side analysts anticipate that Elanco Animal Well being Integrated will submit 1.09 earnings per share for the present fiscal 12 months.
Wall Avenue Analyst Weigh In
Numerous equities analysis analysts lately commented on ELAN shares. Morgan Stanley downgraded Elanco Animal Well being from an “chubby” ranking to an “equal weight” ranking and dropped their worth goal for the corporate from $37.00 to $22.00 in a report on Thursday, August 18th. Piper Sandler decreased their goal worth on Elanco Animal Well being from $22.00 to $21.00 and set a “impartial” ranking for the corporate in a analysis be aware on Tuesday, August sixteenth. Barclays decreased their goal worth on Elanco Animal Well being from $32.00 to $18.00 and set an “equal weight” ranking for the corporate in a analysis be aware on Monday, September twelfth. The Goldman Sachs Group lower Elanco Animal Well being from a “purchase” ranking to a “promote” ranking and decreased their goal worth for the corporate from $32.00 to $19.00 in a analysis be aware on Thursday, July twenty first. Lastly, Stifel Nicolaus decreased their goal worth on Elanco Animal Well being from $30.00 to $22.00 and set a “maintain” ranking for the corporate in a analysis be aware on Friday, June twenty fourth. One funding analyst has rated the inventory with a promote ranking and 5 have issued a maintain ranking to the corporate’s inventory. In keeping with knowledge from MarketBeat.com, Elanco Animal Well being at the moment has a median ranking of “Maintain” and a median worth goal of $21.00.
Elanco Animal Well being Profile
(Get Ranking)
Elanco Animal Well being Integrated, an animal well being firm, innovates, develops, manufactures, and markets merchandise for pets and livestock. It provides pet well being illness prevention merchandise, comparable to parasiticide and vaccine merchandise that defend pets from worms, fleas, and ticks underneath the Seresto, Benefit, Advantix, and Advocate manufacturers; pet well being therapeutics for ache, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines underneath the Galliprant and Claro manufacturers; vaccines, antibiotics, parasiticides, and different merchandise to be used in poultry and aquaculture manufacturing, in addition to dietary well being merchandise, together with enzymes, probiotics, and prebiotics; and a variety of vaccines, antibiotics, implants, parasiticides, and different merchandise utilized in ruminant and swine manufacturing underneath the Rumensin and Baytril manufacturers.
Featured Articles
Need to see what different hedge funds are holding ELAN? Go to HoldingsChannel.com to get the most recent 13F filings and insider trades for Elanco Animal Well being Integrated (NYSE:ELAN – Get Ranking).
Obtain Information & Rankings for Elanco Animal Well being Every day – Enter your electronic mail deal with under to obtain a concise each day abstract of the most recent information and analysts’ rankings for Elanco Animal Well being and associated firms with MarketBeat.com’s FREE each day electronic mail publication.
